On Oct. 23, 2026, The US Centers for Disease Control and Prevention (CDC) reported 4,588 measles cases in…
On Aug. 7, 2026, The Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of…
On Jul. 24, 2026, the number of measles cases in the U.S. surpassed the record-breaking tally for all…
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCE (Pneumococcal…
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…
On Jul. 26, 2022, Novavax announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketing approval from…
On Jul. 5, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
On Oct. 31, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had notified the Company…
On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…
On Sept. 28, 2021, Quest Diagnostics reported that one in two (50.5%) American children under six years of…
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
On Jul. 2, 2021, the National Institutes of Health (NIH) announced funding five additional projects to identify ways…
On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…
On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…
On Oct. 13, 2020, the National Institute on Drug Abuse (NIDA) and nine other institutes, all part of…
On Sept. 25, 2020, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…
On Oct. 14, 2016, Colorado University Boulder researchers will play a key role in a landmark National Institutes…
On Oct. 23, 2015, the Immunization Practices Advisory Committee (ACIP) published recommendations for the use of serogroup B…
On Jun. 12, 2015, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescents and young adults aged…
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) announced it had expanded the approved age…
On Aug. 27, 1999, Merck, West Point, Pennsylvania) received approval from the Food and Drug Administration (FDA) of…
On Sept. 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined…
On Oct. 1, 1994, the U.S. Department of Health and Human Services implemented the Vaccines for Children (VFC)…